01 3Gowling Lafleur Henderson LLP
02 9Gowling WLG (Canada) LLP
01 32216796
02 32389333
03 32514977
04 32632556
01 12Erlotinib
01 12Tablet
01 32015-06-06
02 62020-11-09
03 32024-02-11
Patent Expiration Date : 2020-11-09
Date Granted : 2008-09-02
Brand Name : TARCEVA
Patent Number : 2389333
Filing Date : 2000-11-09
Strength per Unit : 25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-11-09
Date Granted : 2008-09-02
Patent Expiration Date : 2015-06-06
Date Granted : 2003-09-02
Brand Name : TARCEVA
Patent Number : 2216796
Filing Date : 1995-06-06
Strength per Unit : 25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-06-06
Date Granted : 2003-09-02
Patent Expiration Date : 2020-11-09
Date Granted : 2008-09-02
Brand Name : TARCEVA
Patent Number : 2389333
Filing Date : 2000-11-09
Strength per Unit : 100 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-11-09
Date Granted : 2008-09-02
Patent Expiration Date : 2015-06-06
Date Granted : 2003-09-02
Brand Name : TARCEVA
Patent Number : 2216796
Filing Date : 1995-06-06
Strength per Unit : 100 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-06-06
Date Granted : 2003-09-02
Patent Expiration Date : 2020-11-09
Date Granted : 2008-09-02
Brand Name : TARCEVA
Patent Number : 2389333
Filing Date : 2000-11-09
Strength per Unit : 150 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-11-09
Date Granted : 2008-09-02
Patent Expiration Date : 2015-06-06
Date Granted : 2003-09-02
Brand Name : TARCEVA
Patent Number : 2216796
Filing Date : 1995-06-06
Strength per Unit : 150 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-06-06
Date Granted : 2003-09-02
Patent Expiration Date : 2024-02-11
Date Granted : 2010-06-22
Brand Name : TARCEVA
Patent Number : 2514977
Filing Date : 2004-02-11
Strength per Unit : 25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-02-11
Date Granted : 2010-06-22
Patent Expiration Date : 2020-11-09
Date Granted : 2012-01-03
Brand Name : TARCEVA
Patent Number : 2632556
Filing Date : 2000-11-09
Strength per Unit : 25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-11-09
Date Granted : 2012-01-03
Patent Expiration Date : 2024-02-11
Date Granted : 2010-06-22
Brand Name : TARCEVA
Patent Number : 2514977
Filing Date : 2004-02-11
Strength per Unit : 100 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-02-11
Date Granted : 2010-06-22
Patent Expiration Date : 2020-11-09
Date Granted : 2012-01-03
Brand Name : TARCEVA
Patent Number : 2632556
Filing Date : 2000-11-09
Strength per Unit : 100 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-11-09
Date Granted : 2012-01-03
